All posts by: Michael Zand

About Michael Zand

Collaboration to Develop Gene Therapies Delivery – Labmate Online

Continue reading

2017-11-01 NEWS

Collaboration to Develop Gene Therapies Delivery
Labmate Online
A research collaboration is to assess the effectiveness of developing gene therapies using Avacta Group’s Affimer technology combined with FIT Biotech Oy’s gtGTU® platform. The very small, simply structured Affirmer proteins have ideal potential for …

Continue reading

2017-11-01 NEWS

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable
Daily Beast
Straddling this balance is chimeric antigen receptor (CAR) T-cell therapy: a revolutionary cancer treatment where doctors take a patient’s own T-cells (which play a significant role in the body’s cell-mediated immune response), genetically reengineer
Mayo Clinic to Offer CAR T-Cell Therapy for Relapsed Non-Hodgkin LymphomaNewswise (press release)

all 2 news articles »

Continue reading

2017-11-01 NEWS

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable
Daily Beast
Straddling this balance is chimeric antigen receptor (CAR) T-cell therapy: a revolutionary cancer treatment where doctors take a patient’s own T-cells (which play a significant role in the body’s cell-mediated immune response), genetically reengineer
Mayo Clinic to Offer CAR T-Cell Therapy for Relapsed Non-Hodgkin LymphomaNewswise (press release)

all 2 news articles »

Continue reading

2017-11-01 NEWS

Belfast Telegraph

Northern Ireland student spent days in London donating stem cells to save stranger’s life
Belfast Telegraph
“Throughout various placements within hospitals, I had seen first-hand the devastating effect that blood cancer can have on people – the difficulties that can occur in finding a match for a stem cell transplant and the life-changing effect that a

and more »